连续前列腺多参数MRI在主动监测前列腺癌中的诊断准确性与预后价值
该单中心回顾性研究纳入2006至2018年间125例低危前列腺癌主动监测患者,所有患者均在接受确诊活检和后续监测活检前进行多参数MRI(MRI1和MRI2)。结果显示,从MRI1到MRI2,PI-RADS≥3对Gleason分级分组≥2疾病的敏感性从85%提升至91%,阳性预测值从26%提升至49%;PI-RADS评分升高与活检升级和接受确定性治疗独立相关。
要点
- 连续MRI可提高对GG≥2前列腺癌的检出准确性。
- PI-RADS评分升高与活检升级及确定性治疗风险增加相关。
- 持续可见的高级别病变(PI-RADS 4-5)也提示更高风险。
核心结论
- 连续多参数MRI的预后价值随重复检查而提升,可提供额外风险分层。
研究设计与样本
- 单中心回顾性研究,纳入2006至2018年低危前列腺癌主动监测队列中125例男性,中位随访78个月。
主要发现
- 38%的患者出现PI-RADS评分升高。
- PI-RADS≥3对GG≥2疾病的敏感性从MRI1的85%升至MRI2的91%,阳性预测值从26%升至49%。
- 与两次MRI均为PI-RADS 1-3相比,PI-RADS评分从MRI1到MRI2升高与GG≥2疾病相关(OR 4.8,95%CI 1.7-13.2)。
- 两次MRI均为PI-RADS 4-5的患者较两次均为PI-RADS 1-3者GG≥2风险更高(OR 3.3,95%CI 1.3-8.6)。
- PI-RADS评分任何升高均与接受确定性治疗独立相关(HR 3.9,95%CI 1.3-11.9)。
临床怎么用
- 在主动监测中可考虑连续进行多参数MRI,动态评估PI-RADS评分变化以辅助风险分层。
局限性
- 回顾性单中心设计,结果需在其他队列中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multiparametric magnetic resonance imaging (MRI) is increasingly utilized to improve the detection of clinically significant prostate cancer. Evidence for serial MRI in men on active surveillance (AS) is lacking. OBJECTIVE: To evaluate the role of MRI in detecting Gleason grade group (GG) ≥2 disease in confirmatory and subsequent surveillance biopsies for men on AS. DESIGN, SETTING, AND PARTICIPANTS: This was a single-center study of men with low-risk prostate cancer enrolled in an AS cohort between 2006 and 2018. All men were diagnosed by systematic biopsy and underwent MRI prior to confirmatory ("MRI1") and subsequent surveillance ("MRI2") biopsies. MRI lesions were scored with Prostate Imaging Reporting and Data System (PI-RADS) version 2. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The primary outcome was biopsy upgrade to GG ≥ 2 prostate cancer, and the secondary outcome was definitive treatment. Test characteristics for PI-RADS score were calculated. Multivariable logistic and Cox proportional hazard regression models were used to determine the associations between PI-RADS score change and outcomes, on a per-examination basis. RESULTS AND LIMITATIONS: Of 125 men with a median follow-up of 78 mo, 38% experienced an increase in PI-RADS scores. The sensitivity and positive predictive value of PI-RADS ≥3 for GG ≥ 2 disease improved from MRI1 to MRI2 (from 85% to 91% and from 26% to 49%, respectively). An increase in PI-RADS scores from MRI1 to MRI2 was associated with GG ≥ 2 (odds ratio [OR] 4.8, 95% confidence interval [CI] 1.7-13.2) compared with PI-RADS 1-3 on both MRI scans. Men with PI-RADS 4-5 lesions on both MRI scans had a higher likelihood of GG ≥ 2 than patients with PI-RADS 1-3 lesions on both (OR 3.3, 95% CI 1.3-8.6). Importantly, any increase in PI-RADS scores was independently associated with definitive treatment (hazard ratio 3.9, 95% CI 1.3-11.9). This study was limited by its retrospective, single-center design. CONCLUSIONS: The prognostic value of MRI improves with serial examination and provides additional risk stratification. Validation in other cohorts is needed. PATIENT SUMMARY: We looked at the role of serial prostate magnetic resonance imaging in men with low-risk prostate cancer on active surveillance at the University of California, San Francisco. We found that both consistently visible and increasingly suspicious lesions were associated with biopsy upgrade and definitive treatment.
引用
- Chu CE, Cowan JE, Lonergan PE, et al. Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer. Eur Urol Oncol. 2021. PMID: 33483265. doi:10.1016/j.euo.2020.11.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。